Aspirin did not significantly differ from anticoagulants in overall DVT rates following major lower extremity orthopedic surgery (RR 1.15; 95% CI 0.68-1.96).
Meta-Analysis (n=1,408)
Does aspirin prevent venous thromboembolism and reduce bleeding compared to anticoagulants in adult patients after major lower extremity orthopedic surgery?
Aspirin is similarly effective to anticoagulants for VTE prevention after lower extremity arthroplasty and may reduce bleeding risk, though it may be associated with higher DVT risk after hip fracture repair.
Relative Risk: 1.15 (95% CI 0.68–1.96)
BACKGROUND: Hip fracture surgery and lower extremity arthroplasty are associated with increased risk of both venous thromboembolism and bleeding. The best pharmacologic strategy for reducing these opposing risks is uncertain. PURPOSE: To compare venous thromboembolism (VTE) and bleeding rates in adult patients receiving aspirin versus anticoagulants after major lower extremity orthopedic surgery. DATA SOURCES: Medline, Cumulative Index to Nursing and Allied Health Literature, and the Cochrane Library through June 2013; reference lists, ClinicalTrials. gov, and scientific meeting abstracts. STUDY SELECTION: Randomized trials comparing aspirin to anticoagulants for prevention of VTE following major lower extremity orthopedic surgery. DATA EXTRACTION: Two reviewers independently extracted data on rates of VTE, bleeding, and mortality. DATA SYNTHESIS: Of 298 studies screened, 8 trials including 1408 participants met inclusion criteria; all trials screened participants for deep venous thrombosis (DVT). Overall rates of DVT did not differ statistically between aspirin and anticoagulants (relative risk RR: 1. 15 95% confidence interval CI: 0. 68-1. 96). Subgrouped by type of surgery, there was a nonsignificant trend favoring anticoagulation following hip fracture repair but not knee or hip arthroplasty (hip fracture RR: 1. 60 95% CI: 0. 80-3. 20, 2 trials; arthroplasty RR: 1. 00 95% CI: 0. 49-2. 05, 5 trials). The risk of bleeding was lower with aspirin than anticoagulants following hip fracture repair (RR: 0. 32 95% CI: 0. 13-0. 77, 2 trials), with a nonsignificant trend favoring aspirin after arthroplasty (RR: 0. 63 95% CI: 0. 33-1. 21, 5 trials). Rates of pulmonary embolism were too low to provide reliable estimates. CONCLUSION: Compared with anticoagulation, aspirin may be associated with higher risk of DVT following hip fracture repair, although bleeding rates were substantially lower. Aspirin was similarly effective after lower extremity arthroplasty and may be associated with lower bleeding risk. Journal of Hospital Medicine 2014;9: 579-585. © 2014 Society of Hospital Medicine.
Drescher et al. (Thu,) conducted a meta-analysis in Major lower extremity orthopedic surgery (n=1,408). Aspirin vs. Anticoagulants was evaluated on Deep venous thrombosis (DVT) (RR 1.15, 95% CI 0.68-1.96). Aspirin did not significantly differ from anticoagulants in overall DVT rates following major lower extremity orthopedic surgery (RR 1.15; 95% CI 0.68-1.96).